Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny M Despotovic

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Blood|July 9, 2011
Thrombopoiesis: new ITP paradigm?Jenny M Despotovic, Russell E Ware
Hematology/Oncology Clinics of North America|April 30, 2019
Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in ChildrenTaylor Olmsted Kim, Jenny M Despotovic
Hematology. American Society of Hematology. Education Program|December 4, 2018
Pediatric ITP: is it different from adult ITP?Jenny M Despotovic, Amanda B Grimes
Hematology. American Society of Hematology. Education Program|December 10, 2013
Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?Jenny M Despotovic, Cindy E Neunert
Blood|September 1, 2018
IVIg and FcγRIIb in kids with ITP: individualizing therapyJenny M Despotovic, James B Bussel
Pediatric Blood & Cancer|April 22, 2022
Diagnosis, monitoring, and management of pyruvate kinase deficiency in childrenShaniqua Johnson, Rachael F Grace, Jenny M Despotovic
The Journal of Pediatrics|October 3, 2018
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best TreatmentSarah H O'Brien, Jenny M Despotovic, Cindy E Neunert
Pediatric Blood & Cancer|July 2, 2013
Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warningJoel C Thompson, Jennifer Klima, Jenny M Despotovic, et al.
American Journal of Hematology|November 29, 2011
A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expressionPatrick T McGann, Jenny M Despotovic, Thad A Howard, et al.
Patient Preference and Adherence|August 18, 2020
Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of UseMegan M Gilbert, Amanda B Grimes, Taylor Olmsted Kim, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Blood|July 9, 2011
Thrombopoiesis: new ITP paradigm?Jenny M Despotovic, Russell E Ware
Hematology/Oncology Clinics of North America|April 30, 2019
Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in ChildrenTaylor Olmsted Kim, Jenny M Despotovic
Hematology. American Society of Hematology. Education Program|December 4, 2018
Pediatric ITP: is it different from adult ITP?Jenny M Despotovic, Amanda B Grimes
Hematology. American Society of Hematology. Education Program|December 10, 2013
Is anti-D immunoglobulin still a frontline treatment option for immune thrombocytopenia?Jenny M Despotovic, Cindy E Neunert
Blood|September 1, 2018
IVIg and FcγRIIb in kids with ITP: individualizing therapyJenny M Despotovic, James B Bussel
Pediatric Blood & Cancer|April 22, 2022
Diagnosis, monitoring, and management of pyruvate kinase deficiency in childrenShaniqua Johnson, Rachael F Grace, Jenny M Despotovic
The Journal of Pediatrics|October 3, 2018
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best TreatmentSarah H O'Brien, Jenny M Despotovic, Cindy E Neunert
Pediatric Blood & Cancer|July 2, 2013
Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warningJoel C Thompson, Jennifer Klima, Jenny M Despotovic, et al.
American Journal of Hematology|November 29, 2011
A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expressionPatrick T McGann, Jenny M Despotovic, Thad A Howard, et al.
Patient Preference and Adherence|August 18, 2020
Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of UseMegan M Gilbert, Amanda B Grimes, Taylor Olmsted Kim, et al.
Pageof 5